|
|
We offer a monthly newsletter dealing with
the various issues surrounding infectious diseases. To
find out more click
HERE.
|
|
Epidemiology
Hepatitis C Mortality and Complication Rates in New York
Determined
Epidemiology Hepatitis C Mortality and Complication Rates
in New York Determined
Article:
New York State Department of Health epidemiologists
recently reviewed and compiled the mortality and complication
rates for hospital patients with hepatitis C (HepC) virus in
Upstate New York.
A report of these findings was presented by P.F. Smith and
associates at the 2000 International Conference on Emerging
Infectious Diseases, held in July, 2000 in Atlanta, Georgia.
The conference was hosted by the U.S. Centers for Disease
Control and Prevention. The Smith et al. presentation was
titled "Mortality and Chronic Complications Among Persons
Dying with Hepatitis C, Upstate New York, 1997."
This review was performed by comparing patient
hospitalization discharge records for cause of death with
Upstate New York 1997 multiple cause of death records. Records
for patients within New York City were omitted from the
review.
"Their medical records were reviewed to verify the
diagnosis of HepC, ascertain the presence of
hepatitis-associated complications, and determine the risk
factors for HepC," researchers said.
More than 500 records were initially obtained from
hospitals, with 273 of those being officially included in the
study. A total of 80 patients for which medical records were
available had a diagnosis that mentioned hepatitis C.
Approximately 60% of the 80 patients were male and of white
race. The following complication rates were determined based
on record review:
Encephalopathy (43%)
Cirrhosis (81%)
Hepatocellular carcinoma (6%)
Renal failure (59%)
Gastrointestinal bleeding (31%)
Additional data showed some patients to be coinfected with
human immunodeficiency virus (HIV) and hepatitis B virus (HBV)
at rates of 19% and 21%, respectively.
The investigators determined that in at least 75 of the 80
cases, hepatitis C related complications were a cause of
death.
Previous drug use and receipt of blood products were two
risk factors for Hepatitis C Virus infection identified by Smith et al.,
however, documentation was scarce in this area, so other risk
factors could not be identified.
"Matching HepC hospitalization deaths with death
certificates gave a minimal estimate of 491 deaths
(4.5/100,000) with HepC in Upstate NY in 1997," Smith et
al. reported.
Smith and associates concluded that their data were
comparable to previously reported estimates for Hepatitis C Virus mortality.
"Diagnosis of patients with HepC is important for
appropriate counseling and care in order to decrease
complications and mortality from HepC," they said.
More than 30 additional articles on the topic of hepatitis
C and mortality can be seen at the online database at
www.NewsRx.com.
The corresponding author for this study is P.F. Smith, New
York State Department of Health, Division of Epidemiology, New
York, USA.
Key points reported in this study are:
The rate for hepatitis C virus related deaths is
4.5/100,000 persons in Upstate New York
Renal failure, encephalopathy, and cirrhosis are some
of the identified hepatitis C virus complications that lead to
death
Mortality and complications from hepatitis C virus
infection can be prevented with proactive diagnostic and
treatment efforts
|